查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600157

微創青光眼手術設備市場：按設備、適應症、手術、最終用戶分類 - 全球預測 2025-2030

Minimally Invasive Glaucoma Surgery Devices Market by Device (Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices), Indication (Closed-Angle Glaucoma, Open-Angle Glaucoma), Surgery, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年微創青光眼手術器械市值為5.0135億美元，預計2024年將達到5.2662億美元，複合年成長率為5.35%，2030年將達到7.2255億美元。

微創青光眼手術 (MIGS) 設備旨在降低眼內壓，主要用於輕度至中度青光眼患者。由於它比傳統手術方法侵入性更小，因此已成為眼科手術中極其重要的發展。 MIGS 設備的範圍涵蓋了由於世界人口老化、青光眼盛行率不斷上升以及對更安全的替代治療的需求而產生的需求。這些裝置可以以多種形式應用，包括支架和分流器，並且通常由眼科醫生單獨使用或與白內障手術結合使用。最終用途範圍包括診所、醫院和門診手術中心，但由於擁有熟練的專業人員和先進的設備，醫院目前佔據主導地位。

主要市場統計
基準年[2023] 50135萬美元
預測年份 [2024] 5.2662億美元
預測年份 [2030] 72255萬美元
複合年成長率（%） 5.35%

MIGS 市場的主要成長動力包括與老齡化相關的眼部疾病發生率的上升以及對青光眼的認知的提高。此外，對門診手術日益成長的偏好也支持了市場的擴張。有開發先進且具有成本效益的設備的機會，以提高發展中地區的可及性和採用率。鼓勵公司投資專注於升級技術和探索新手術技術的研究和合作關係。然而，該市場受到 MIGS 設備成本高、術後併發症的可能性以及訓練有素的專業人員數量有限的限制。

某些地區嚴格的監管要求和缺乏報銷政策等挑戰也可能阻礙市場成長。為了促進創新，公司應專注於開發下一代生物相容性材料並提高設備可用性，這可以進一步擴大應用範圍。探索針對患者的治療方案和個人化照護模式是業務成長的寶貴前沿。 MIGS市場的特點是競爭溫和，主要參與者專注於研發以保持競爭優勢。

市場動態：快速發展的微創青光眼手術器材市場的關鍵市場洞察

供需的動態交互作用正在改變微創青光眼手術器械市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 對微創手術設備的偏好日益成長
    • 世界老年人口的增加
    • 提高對青光眼早期檢測的認知促進了微創手術設備的採用
  • 市場限制因素
    • 微創青光眼手術設備成本高
  • 市場機會
    • 加大研發投入，創新有效的青光眼手術器械
    • 遠端醫療和遠端患者監護的進展
  • 市場挑戰
    • 引進新的青光眼手術設備存在監管障礙和漫長的核准流程

波特五力：駕馭微創青光眼手術器械市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解微創青光眼手術器械市場的外部影響

外部宏觀環境因素在塑造微創青光眼手術器械市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解微創青光眼手術器材市場競爭狀況

對微創青光眼手術設備市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣微創青光眼手術器械市場供應商的績效評估

FPNV 定位矩陣是評估微創青光眼手術設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，以規劃微創青光眼手術器材市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對微創青光眼手術器械市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對微創手術設備的偏好增加
      • 全球人口老化仍在持續
      • 人們對青光眼早期檢測的認知不斷提高，正在推動微創手術設備的引進
    • 抑制因素
      • 微創青光眼手術設備成本高
    • 機會
      • 加大研發投入，創新有效的青光眼手術器械
      • 遠端醫療和遠端患者監護的進展
    • 任務
      • 引進新的青光眼手術設備需要監管障礙和漫長的核准過程
  • 市場區隔分析
    • 設備：早期至中期青光眼患者對微支架的青睞度增加
    • 最終用戶：醫院對微創青光眼手術 (MIGS) 設備的需求增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章微創青光眼手術器械市場：依器械分類

  • 微型支架
  • 脈絡膜上腔裝置
  • 小梁裝置
  • 粘膜吻合器

第7章微創青光眼手術器械市場（按適應症）

  • 隅角閉鎖性青光眼
  • 開放性青光眼

第8章依手術分類的微創青光眼手術器械市場

  • 從外部
  • 內部

第9章微創青光眼手術器械市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 眼科診所

第10章北美及南美微創青光眼手術器械市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太微創青光眼手術器械市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲微創青光眼手術器械市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 新世界醫療增強型 Kahook 雙刀片獲得 510(k) 批准，擴大青光眼治療選擇和市場覆蓋範圍
    • Cytosciences 的 OMNI 手術系統在治療青光眼方面顯示出良好的效果，我們預計會有更廣泛的採用和市場成長。
    • iSTAR Medical SA青光眼治療儀獲得CE標誌，進軍美國市場
  • 戰略分析和建議

公司名單

  • Abbott Medical Optics, Inc.
  • Alcon Inc.
  • Allergan PLC
  • Bausch & Lomb Inc.
  • Carl-Zeiss AG
  • Corza Ophthalmology
  • Ellex Medical Lasers Ltd.
  • Glaukos Corporation
  • InnFocus Inc.
  • IOPtima
  • iSTAR Medical
  • Ivantis, Inc.
  • Lumenis Be Ltd.
  • Neomedix Corporation
  • New World Medical, Inc.
  • Optonol Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • Sight Sciences, Inc.
  • Topcon Corporation
Product Code: MRR-036C5CF3A869

The Minimally Invasive Glaucoma Surgery Devices Market was valued at USD 501.35 million in 2023, expected to reach USD 526.62 million in 2024, and is projected to grow at a CAGR of 5.35%, to USD 722.55 million by 2030.

Minimally Invasive Glaucoma Surgery (MIGS) devices are designed to reduce intraocular pressure and are primarily used in patients with mild-to-moderate glaucoma. Their less invasive nature compared to traditional surgical methods makes them a pivotal development in ophthalmic surgery. The scope of MIGS devices encompasses their necessity due to the aging global population, the increasing prevalence of glaucoma, and the demand for safer alternative treatments. These devices are applicable in various forms, including stents and shunts, which are regularly used by ophthalmologists in both standalone procedures and in conjunction with cataract surgery. End-use scope includes clinics, hospitals, and ambulatory surgical centers, with hospitals currently dominating due to the availability of skilled professionals and advanced facilities.

KEY MARKET STATISTICS
Base Year [2023] USD 501.35 million
Estimated Year [2024] USD 526.62 million
Forecast Year [2030] USD 722.55 million
CAGR (%) 5.35%

The key growth drivers of the MIGS market include the rising incidence of age-related eye disorders and increasing awareness regarding glaucoma. Additionally, the growing preference for outpatient surgical procedures boosts market expansion. Opportunities lie in developing advanced, yet more cost-effective devices to increase accessibility and adoption in developing regions. Companies are recommended to invest in research and partnerships focused on technology upgrades and exploring new surgical techniques. However, the market faces limitations due to the high cost of MIGS devices, potential complications post-surgery, and a limited number of skilled professionals.

Challenges like stringent regulatory requirements and lack of reimbursement policies in certain regions could impede market growth. To foster innovation, businesses should focus on the development of next-generation biocompatible materials and enhancing device user-friendliness, which could further broaden their application range. Research into patient-specific treatment options and personalized care models represents a valuable frontier for business growth. The MIGS market is characterized by moderate competition, with key players focused on R&D to maintain competitive advantages and the entry of new companies bringing innovative solutions expected to invigorate the sector further.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minimally Invasive Glaucoma Surgery Devices Market

The Minimally Invasive Glaucoma Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the preference for minimally invasive surgery devices
    • Rising geriatric population globally
    • Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
  • Market Restraints
    • High costs of minimally invasive glaucoma surgery devices
  • Market Opportunities
    • Increasing investment in research and development for innovative and effective glaucoma surgery devices
    • Advancements in telemedicine and remote patient monitoring
  • Market Challenges
    • Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices

Porter's Five Forces: A Strategic Tool for Navigating the Minimally Invasive Glaucoma Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minimally Invasive Glaucoma Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minimally Invasive Glaucoma Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minimally Invasive Glaucoma Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minimally Invasive Glaucoma Surgery Devices Market

A detailed market share analysis in the Minimally Invasive Glaucoma Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minimally Invasive Glaucoma Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minimally Invasive Glaucoma Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minimally Invasive Glaucoma Surgery Devices Market

A strategic analysis of the Minimally Invasive Glaucoma Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Glaucoma Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Corza Ophthalmology, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis Be Ltd., Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Glaucoma Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices, and Viscocanalostomy Devices.
  • Based on Indication, market is studied across Closed-Angle Glaucoma and Open-Angle Glaucoma.
  • Based on Surgery, market is studied across Ab Externo and Ab Interno.
  • Based on End-User, market is studied across Ambulatory Surgical Center, Hospital, and Ophthalmology Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the preference for minimally invasive surgery devices
      • 5.1.1.2. Rising geriatric population globally
      • 5.1.1.3. Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of minimally invasive glaucoma surgery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment in research and development for innovative and effective glaucoma surgery devices
      • 5.1.3.2. Advancements in telemedicine and remote patient monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device : Increasing preference for micro-stents for patients in the early-to-moderate stages of glaucoma
    • 5.2.2. End-user : Growing demand for minimally invasive glaucoma surgery (MIGS) devices in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minimally Invasive Glaucoma Surgery Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Micro-Stents
  • 6.3. Suprachoroidal Devices
  • 6.4. Trabecular Meshwork Devices
  • 6.5. Viscocanalostomy Devices

7. Minimally Invasive Glaucoma Surgery Devices Market, by Indication

  • 7.1. Introduction
  • 7.2. Closed-Angle Glaucoma
  • 7.3. Open-Angle Glaucoma

8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery

  • 8.1. Introduction
  • 8.2. Ab Externo
  • 8.3. Ab Interno

9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital
  • 9.4. Ophthalmology Clinic

10. Americas Minimally Invasive Glaucoma Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. New World Medical Secures 510(k) Clearance for Expanded Kahook Dual Blade, Enhancing Glaucoma Treatment Options and Market Reach
    • 13.3.2. OMNI Surgical System by Sight Sciences Shows Promising Results in Glaucoma Treatment, Anticipating Wider Adoption and Market Growth
    • 13.3.3. iSTAR Medical SA Achieves CE Mark for Glaucoma Device, Eyes Expansion into U.S. Market
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Medical Optics, Inc.
  • 2. Alcon Inc.
  • 3. Allergan PLC
  • 4. Bausch & Lomb Inc.
  • 5. Carl-Zeiss AG
  • 6. Corza Ophthalmology
  • 7. Ellex Medical Lasers Ltd.
  • 8. Glaukos Corporation
  • 9. InnFocus Inc.
  • 10. IOPtima
  • 11. iSTAR Medical
  • 12. Ivantis, Inc.
  • 13. Lumenis Be Ltd.
  • 14. Neomedix Corporation
  • 15. New World Medical, Inc.
  • 16. Optonol Ltd.
  • 17. Santen Pharmaceutical Co., Ltd.
  • 18. Sight Sciences, Inc.
  • 19. Topcon Corporation

LIST OF FIGURES

  • FIGURE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY MICRO-STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SUPRACHOROIDAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY TRABECULAR MESHWORK DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY VISCOCANALOSTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY CLOSED-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPEN-ANGLE GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. MINIMALLY INVASIVE GLAUCOMA SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023